medigraphic.com
ISSN 2225-4676 (Electronic)

2014, Number 2

<< Back Next >>

Rev Cubana Neurol Neurocir 2014; 4 (2)

Rebleeding from ruptured intracranial aneurysms: epidemiology, associated factors, physiopathology, and treatment

Rivero RD, Scherle MCE

Language: Spanish
References: 49
Page: 184-191
PDF size: 251.30 Kb.


ABSTRACT

Objective: To review the recent aspects about epidemiology, related factors, physiopathology and treatment in rebleeding associated with aneurismatic subarachnoid haemorrhage.
Development: Rebleeding is the most important cause of morbidity and mortality in patients with aneurismatic subarachnoid haemorrhage. There are factors associated with increase of this complication in many studies: systolic hypertension (more than 160 mm Hg), poor clinical condition at symptoms onset, intracerebral hematoma, size of the aneurism and sentinel headache. The main physiopathology mechanisms related are transmural pressure, fibrinolysis and coagulation system disorders. The administration of antifibrinolitic treatment in the first three days of subaracnoidea haemorrhage had been show decrease of rebleeding rate, also associated with the early surgery (conventional or endovascular).
Conclusions: Some factors are related with rebleeding, but are not clear the causal effect of them. The early surgery and short antifibrinolitic therapy had been the most useful treatment to prevent aneurismatic rebleeding.


REFERENCES

  1. Albuquerque FC. Rebleeding and its prevention after subarachnoid hemorrhage. World Neurosurg. 2013 Feb;79(2):245–6. doi: 10.1016/j.wneu.2012.07.025.

  2. Starke RM, Connolly ES Jr. Rebleeding after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2011;15(2):241–6.

  3. Rabinstein AA, Lanzino G, Wijdicks EFM. Multidisciplinary management and emerging therapeutic strategies in aneurysmal subarachnoid haemorrhage. Lancet Neurol. 2010;9:504–19.

  4. Rodríguez García PL, Rodríguez García D. Hemorragia Subaracnoidea: Epidemiologia, etiología, fisiopatología y diagnóstico. Rev Cubana Neurol Neurocir. [Internet] 2011 [citado 5.01.2014];1(1):59–73. Disponible en: http://www.revneuro.sld.cu/index.php/neu/article/view/11

  5. Pérez Nellar J, Scherle Matamoros C, Montes de Oca F, González González J, Hierro García D. Demora en la llegada de pacientes con hemorragia subaracnoidea a un hospital terciario. Rev Neurol. 2009;49(10):524–8.

  6. Kassell NF, Torner JC. Aneurysmal rebleeding: a preliminary report from the Cooperative Aneurysm Study. Neurosurgery. 1983;13(5):479–81.

  7. Jane JA, Winn HR, Richardson AE. The natural history of intracranial aneurysms: rebleeding rates during the acute and long term period and implication for surgical management. Clin Neurosurg. 1977;24:176–84.

  8. Larsen CC, Astrup J. Rebleeding after aneurysmal subarachnoid hemorrhage: a literature review. World Neurosurg. 2013 Feb;79(2):307–12. doi: 10.1016/j.wneu.2012.06.023.

  9. Laidlaw JD, Siu KH. Ultra–early surgery for aneurysmal subarachnoid hemorrhage: outcomes for a consecutive series of 391 patients not selected by grade or age. J Neurosurg. 2002;97(2):250–8.

  10. González Aguirre Y, Varela Hernández A, Casares Albernas F, Herrera Lorenzo O, Infante Ferrer J, Morgado Castañeda R. Comportamiento de la hemorragia subaracnoidea espontánea en el Hospital Universitario ―Manuel Ascunce Domenéch‖. Rev Cubana Neurol Neurocir. [Internet] 2012 [citado 5.01.2014];2(1):17–22. Disponible en: http://www.revneuro.sld.cu/index.php/neu/article/view/32

  11. Acosta Rodríguez L, Mustelier Fernández C, Molero Segrera M, Molero Seguera M. Ictus Hemorrágico. Comportamiento Epidemiológico. Rev Cubana Med. 2002;41(1):7–11.

  12. González González Justo L, Hernández Zayas Humberto, Brown Jaquinet Elizabet, Jongh Cobo Enrique, Gómez Viera Nelson. Factores que influyen sobre los resultados del tratamiento quirúrgico en aneurismas de la arteria cerebral media (Hospital «Hermanos Ameijeiras», 1983 a 2004). Rev Cubana Cir [revista en la Internet]. 2007 Sep [citado 5.01.2014];46(3). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034–74932007000300001&lng=es

  13. Alemán Rivera A, Camacho Gómez A, Aniceto Díaz JA, Amado Donestevez A, Treto Rosal J. Resultados del tratamiento quirúrgico de los aneurismas del complejo cerebral anterior– arteria comunicante anterior. Rev Cubana Cirugía. 2001;40(2):92–8.

  14. Pérez NJ, Scherle MC, Roselló SH, Fernández CL. La Unidad de Ictus modifica las características de la atención del ictus en un hospital terciario. Rev Cubana Neurol Neurocir [Internet] 2011 [citado 5.01.2014];1(1):3–6. http://www.revneuro.sld.cu/index.php/neu/article/view/3

  15. Molyneux A, Kerr R, Stratton I, Sandercock P, Clarke M, Shrimpton J. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial. Lancet 2002;360:1267–74.

  16. Van der Schaaf I, Algra A, Wermer M, Molyneux A, Clarke Mike J, van Gijn J and col. Endovascular coiling versus neurosurgical clipping for patients with aneurysmal subarachnoid hemorrhage. Cochrane Database of Systematic Reviews. 2013. In: The Cochrane Library, Issue 2, Art. No. CD003085. DOI:10.1002/14651858.CD003085.pub4.

  17. Connolly ES, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, et al. Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2012;43(6):1–27.

  18. Cha KC, Kim JH, Kang HI, Moon BG, Lee SJ, Kim JS. Aneurysmal rebleeding: factors associated with clinical outcome in the rebleeding patients. J Korean Neurosurg Soc. 2010;47(2):119–23.

  19. Tong Y, Gu J, Fan WJ, Yu JB, Pan JW, Wan S, Zhou YQ, Zheng XJ, Zhan RY. Patients with supratentorial aneurismal subarachnoid hemorrhage during the intermediate period: waiting or actively treating. Int J Neurosci. 2009;119(9):1494–506.

  20. Ruigrok YM, Slooter AJ, Rinkel GJ, Wijmenga C, Rosendaal FR. Genes influencing coagulation and the risk of aneurysmal subarachnoid hemorrhage, and subsequent complications of secondary cerebral ischemia and rebleeding. Acta Neurochir (Wien). 2010;152(2):257–62.

  21. Molyneux AJ, Kerr RS, Yu LM, Clarke M, Sneade M, Yarnold JA, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomized comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet. 2005;366(9488):809–17.

  22. Tanno Y, Homma M, Oinuma M, Kodama N, Ymamoto T. Rebleeding from ruptured intracranial aneurysms in North Eastern Province of Japan. A cooperative study. J Neurol Sci. 2007;258:11–6.

  23. Heelingman CA, van den Bergh WM, Beijer IS, van Dijk GW, Algra A, van Gijn J et al. Risk of rebleeding after treatment of acute hydrocephalus in patients with aneurysmal subarachnoid hemorrhage. Stroke. 2007;38(1):96–9.

  24. Machiel Pleizier C, Algra A, Velthuis BK, Rinkel GJ. Relation between size of aneurysms and risk of rebleeding in patients D. Rivero Rodríguez et al Rev Cubana Neurol Neurocir. 190 2014;4(2):184–91 with subarachnoid haemorrhage. Acta Neurochir. 2006;148(12):1277–9.

  25. Beck J, Raabe A, Szelenyi A, Berkefeld J, Gerlach R, Setzer M, et al. Sentinel headache and the risk of rebleeding after aneurysmal subarachnoid hemorrhage. Stroke. 2006;37(11):2733–7.

  26. Kitsuta Y, Suzuki N, Sugiyama M, Yamamoto I. Changes in level of consciousness and association with hyperglycemia as tool for predicting and preventing re–bleeding after spontaneous subarachnoid hemorrhage. Prehosp Disaster Med. 2006;21(3):190–5.

  27. Ruijs AC, Dirven CM, Algra A, Beijer I, Vandertop WP, Rinkel G. The risk of rebleeding after external lumbar drainage in patients with untreated ruptured cerebral aneurysms. Acta Neurochir. 2005;147(11):1157–61.

  28. Naidech AM, Ianjua N, Kreiter KT, Ostapkovich ND, Fitzsimmons BF, Parra A, et al. Predictors and impact of aneurysm rebleeding after subarachnoid hemorrhage. Arch Neurol. 2005;62(3):410–6.

  29. McIver JI, Friedman JA, Wijdicks EF, Piepgras DG, Pichelmann MA, Toussaint LG Iii, et al. Preoperative ventriculostomy and rebleeding after aneurysmal subarachnoid hemorrhage. J Neurosurg. 2002;97(5):1042–4.

  30. Ando T, Sakai N, Yamada H, Iwai T, Nishimura Y, Hirata T, Funakoshi T, Takada M. Analysis of reruptured cerebral aneurysms and the prophylactic effects of barbiturate therapy on the early stage. Neurol Res. 1989;11(4):245–8.

  31. Fujii Y, Takeuchi S, Sasaki O, Minakawa T, Koike T, Tanaka R. Ultra–early rebleeding in spontaneous subarachnoid hemorrhage. J Neurosurg. 1996;84(1):35–42.

  32. Ohkuma H, Tsurutani H, Suzuki S. Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management. Stroke. 2001;32(5):1176–80.

  33. Inagawa T, Kamiya K, Ogasawara H, Yano T. Rebleeding of ruptured intracranial aneurysms in the acute stage. Surg Neurol. 1987;28(2):93–9.

  34. Kusumi M, Yamada M, Kitahara T, Endo M, Kan S, Iida H, Sagiuchi T, Fujii K.Rerupture of cerebral aneurysms during angiography—a retrospective study of 13 patients with subarachnoid hemorrhage. Acta Neurochir (Wien). 2005;147(8):831–7.

  35. Larsen CC, Sorensen B, Nielsen JD, Astrup J. Reduced clot–stability during the first 6 hours after aneurysmal subarachnoid haemorrhage––a prospective case–control study Thromb Res. 2012 May;129(5):e229–32. doi: 10.1016/j.thromres.2012.01.016.

  36. Ilveskero S, Juvela S, Siironen J, Lassila R. D–dimerpredicts outcome after aneurysmal subarachnoid hemorrhage: no effect of thromboprophylaxis on coagulation activity. Neurosurgery. 2005;57(1):16–24.

  37. Mutch NJ, Thomas L, Moore NR, Lisiak KM, Booth NA. TAFIa, PAI–1 and alpha–antiplasmin: complementary roles in regulating lysis of thrombi and plasma clots. J Thromb Haemost. 2007;5(4):812–7.

  38. Muszbek L, Bagoly Z, Bereczky Z, Katona E. The involvement of blood coagulation factor XIII in fibrinolysis and thrombosis. Cardiovasc Hematol Agents Med Chem. 2008;6(3):190–205.

  39. Yin C, Ruan J, Jiang L, Zhou S, Sun X. The relationship between rebleeding after spontaneous SAH and APOE polymorphisms in a Chinese population. Int J Neurosci. 2012 Aug;122 (8):472–6. doi: 10.3109/00207454.2012.678445.

  40. Hockel K, Schöller K, Trabold R, Nussberger J, Plesnila N. Vasopressin V(1a) receptors mediate posthemorrhagic systemic hypertension thereby determining rebleeding rate and outcome after experimental subarachnoid hemorrhage. Stroke. 2012 Jan;43 (1):227–32. doi: 10.1161/STROKEAHA.111.626168.

  41. Peacock FW, Angeles JE, Soto KM, Lumb PD, Varon J. Parenteral clevidipine for the acute control of blood pressure in the critically ill patient:a review. Ther Clin Risk Manag. 2009 Jun [citado 5.01.2014];5(3):627–34. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19707278

  42. Harrigan MR, Rajneesh KF, Ardelt AA, Fisher WS. Short–term antifibrinolytic therapy before early aneurysm treatment in subarachnoid hemorrhage: effects on rehemorrhage, cerebral ischemia, and hydrocephalus. Neurosurgery. 2010;67:935–9.

  43. Starke RM, Kim GH, Fernandez A, Komotar RJ, Hickman ZL, Otten ML, Ducruet AF, et al. Impact of a policy of early antifibrinolytic therapy for the prevention of acute rebleeding after aneurysmal subarachnoid hemorrhage. Stroke. 2008;39(9): 2617–21.

  44. Hillman J, Fridriksson S, Nilsson O, Yu Z, Saveland H, Jakobsson KE. Immediate administration of tranexamic acid andreduced incidence of early rebleeding after aneurysmal subarachnoid hemorrhage: a prospective randomized study. J Neurosurg. 2002;97:771–8.

  45. McCormack PL. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis. Drugs. 2012 Mar 26;72(5):585–617. doi: 10.2165/11209070–000000000–00000.

  46. Li H, Pan R, Wang H, Rong X, Yin Z, Milgrom DP, Shi X, Tang Y, Peng Y. Clipping Versus Coiling for Ruptured Intracranial Aneurysms: A Systematic Review and Meta–Analysis. Stroke. 2013;44(1):29–37.

  47. Wagner I, Hauer EM, Staykov D, Volbers B, Dörfler A, Schwab S, Bardutzky J. Effects of continuous hypertonic saline infusion on perihemorrhagic edema evolution. Stroke. 2011;42:1540–5.

  48. Seule MA, Muroi C, Mink S, Yonekawa Y, Keller E. Therapeutic hypothermia in patients with aneurysmal subarachnoid hemorrhage, refractory intracranial hypertension, or cerebral vasospasm. Neurosurgery 2009;64:86–92.

  49. Nagel A, Graetz D, Vajkoczy P, Sarrafzadeh AS. Decompressive craniectomy in aneurysmal subarachnoid hemorrhage: relation to cerebral perfusion pressure and metabolism. Neurocrit Care. 2009;11:384–94.




2020     |     www.medigraphic.com